Presepsin Levels and Neutrophil-to-Lymphocyte Ratio are Positively Correlated with Procalcitonin Levels in Early Onset Neonatal Sepsis

Ni Putu Sukma Sumantri Prabandari, Ni Kadek Mulyantari, Made Sukmawati, Anak Agung Ngurah Subawa, I Wayan Gede Artawan Eka Putra, Anak Agung Wiradewi Lestari, I Nyoman Wande, Ni Nyoman Mahartini


BACKGROUND: Early-onset neonatal sepsis (EONS) is an acute infection and sepsis occurring within the first 24 hours of new-born life. An increase in procalcitonin levels, presepsin levels, and neutrophil-to-lymphocyte ratio (NLR) in EONS subjects have been reported. However, whether presepsin levels and NLR affect the procalcitonin levels in EONS patients who have received antibiotic therapy has not been certainly known. This study was conducted to determine the correlation between presepsin levels and NLR with procalcitonin levels in EONS subjects.

METHODS: A cross-sectional study involving 52 EONS subjects were conducted, and blood samples from subjects were collected. Presepsin levels were examined by enzyme-linked immunosorbent assay (ELISA) method, NLR was calculated from the absolute number of neutrophils divided by the absolute number of lymphocytes, and procalcitonin levels were examined by chemiluminescent microparticle immunoassay (CMIA) method.

RESULTS: Median of procalcitonin levels and presepsin levels were 0.435 (0.12-9.11) ng/mL and 108.33 (71.43-1287.76) ng/L, respectively. While NLR value was 1.68 (0.2-7.52). There was significant difference between procalcitonin and presepsin levels (p=0.000), and so does between procalcitonin levels and NLR (p=0.001). Based on the multivariate analysis, presepsin levels also affected the procalcitonin levels (p=0.000; 95% CI: 0.001-0.004).

CONCLUSION: The results of the study showed that there was significant correlation between presepsin levels and NLR with procalcitonin levels in EONS patients, suggesting that presepsin levels, NLR, and procalcitonin levels are potential candidates for EONS biomarkers.

KEYWORDS: EONS, NLR, presepsin, procalcitonin

Full Text:



UNICEF [Internet]. New York: UNICEF; ©2020. Neonatal Mortality [update 2021 Dec; cited 2022 Jan 2]. Available from:

WHO [Internet]. Geneva: WHO; ©2020. Newborns: Improving Survival and Well-Being [update 2022; cited 2022 Jan 2]. Available from:

Dauhan AC, Lubis AD. Vasoactive-inotropic score for early fetection and mortality prediction of sepsis in children. Indones Biomed J. 2021; 13(1): 34-9, CrossRef.

SMF Ilmu Kesehatan Anak RSUP Sanglah. Panduan Praktik Klinis Sepsis Neonatorum. Denpasar: PPK Rawat Inap Ilmu Kesehatan Anak RSUP Sanglah; 2017.

Assa NP, Artana IWD, Kardana IM, Putra PJ, Sukmawati M. The characteristics of neonatal sepsis in low birth weight (LBW) infants at Sanglah General Hospital, Bali, Indonesia. Intisari Sains Medis. 2020; 11(1): 172-8, CrossRef.

Gomella TL, Eyal FG, Mohammed FB. Gomella's Neonatology. New York: McGraw Hill; 2020, NLMID.

Kamel MM, Abdullah HF, Sayed MAE, Aziz RAA. Presepsin as an early predictor of neonatal sepsis. Int J Pediatr. 2021; 9(4): 13359-69, article.

Priyanka T, Hemalata. Basic haematological scoring system - Is it the most accurate neonatal sepsis predictor? Natl J Lab Med. 2018; 7(3): 29-33, CrossRef.

Chandra R, Pudjiadi AH, Dewi R. Citrullinated histone H3 level as a novel biomarker in pediatric clinical sepsis. Indones Biomed J. 2021; 13(3): 316-23, CrossRef.

Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019; 20(21): 5376, CrossRef.

Hincu MA, Zonda GI, Stanciu GD, Nemescu D, Paduraru L. Relevance of biomarkers currently in use or research for practical diagnosis approach of neonatal early-onset sepsis. Children. 2020; 7(12): 309, CrossRef.

Sitar ME, Ipek BO, Karadeniz A. Procalcitonin in the diagnosis of sepsis and correlations with upcoming novel diagnostic markers. Int J Med Biochem. 2019; 2(3): 132-40, CrossRef.

Memar MY, Baghi HB. Presepsin: A promising biomarker for the detection of bacterial infections. Biomed Pharmacother. 2019; 111: 649-56, CrossRef.

Parri N, Trippella G, Lisi C, De Martino M, Galli L, Chiappini E. Accuracy of presepsin in neonatal sepsis: systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2019; 17(4): 223-32, CrossRef.

PHC [Internet]; Tokyo: PHC Corporation; ©2021. PATHFAST™ - Sepsis Marker : Presepsin [update 2022; cited 2022 Jan 2]. Available from:

Piccioni A, Santoro MC, de Cunzo T, Tullo G, Cicchinelli S, Saviano A, et al. Presepsin as early marker of sepsis in emergency department: A narrative review. Medicina. 2021; 57(8): 770, CrossRef.

Martins EC, Silveira LDF, Viegas K, Beck AD, Junior GF, Cremonese RV, et al. Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study. Rev Bras Ter Intensiva. 2019; 31(1): 63-70, CrossRef.

Dahlan MS. Statistik untuk Kedokteran dan Kesehatan. Edisi 6. Jakarta: Epidemiologi Indonesia; 2014.

Abbott Laboratories. Alinity i B∙R∙A∙H∙M∙S PCT Reagent Kit. Ireland: Abbott; 2017.

Abbott Laboratories. Alinity i B∙R∙A∙H∙M∙S PCT Controls. Ireland: Abbott; 2018.

Bioassay Technology Laboratory [Internet]. Birmingham: Bioassay Technology Laboratory; ©2021. Human Presepsin ELISA Kit [cited 2022 Jan 2]. Available from:

Li T, Dong G, Zhang M, Xu Z, Hu Y, Xie B, et al. Association of neutrophil-lymphocyte ratio and the presence of neonatal sepsis. J Immunol Res. 2020; 2020: 7650713, CrossRef.

Novita C, Hernaningsih Y, Wardhani P, Veterini AS. The correlation between leucocyte CD64, immature granulocyte, and presepsin with procalcitonin in bacterial sepsis patient. Bali Med J. 2019; 8(2): 327-32, CrossRef.

Malgorzata S, Jakub B, Anna S, Anna PB, Aneta S, Urszula GS, et al. Diagnostic value of presepsin (Scd14-St subtype) evaluation in the detection of severe neonatal infections. Int. J Res Stud Biosci. 2015; 3(1): 110-6, article.

Ozdemir AA, Elgormus Y. Diagnostic value of presepsin in detection of early-onset neonatal sepsis. Am J Perinatol. 2017; 34(6): 550-6, CrossRef.

Medscape [Internet]. New York: Medscape; ©2019. Neonatal Sepsis [update 2022; cited 2022 Jan 2]. Available from:

Noah F, Doya LJ, Jouni O. Perinatal risk factors and early onset of neonatal sepsis. Int J Pediatr Res. 2022; 8(1): 088, CrossRef.

Milton R, Gillespie D, Dyer C, Taiyari K, Carvalho MJ, Thomson K, et al. Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study. Lancet Glob Health. 2022; 10(5): e661-e672, CrossRef.

Towers CV, Yates A, Zite N, Smith C, Chernicky L, Howard B. Incidence of fever in labor and risk of neonatal sepsis. Am J Obstet Gynecol. 2017; 216(6): 596.e1-596.e5, CrossRef.

Suhartono E, Yunanto A, Hartoyo E, Kania N, Utama AA, Sari RK, et al. UV-visible spectrophotometric as a prospective tool in neonatal sepsis. Indones Biomed J. 2018; 10(1): 74-8, CrossRef.

Kumar N, Dayal R, Singh P, Pathak S, Pooniya V, Goyal A, et al. A comparative evaluation of presepsin with procalcitonin and CRP in diagnosing neonatal sepsis. Indian J Pediatr. 2019; 86(2): 177-9, CrossRef.

Venugopalan DP, Pillai G, Krishnan S. Diagnostic value and prognostic use of presepsin versus procalcitonin in sepsis. Cureus. 2019; 11(7): e5151, CrossRef.

Rehman FU, Khan A, Aziz A, Iqbal M, Mahmood SBZ, Ali N. Neutrophils to lymphocyte ratio: Earliest and efficacious markers of sepsis. Cureus. 2020; 12(10): 2-7, CrossRef.

Burtis CA, Ashwood ER, Bruns DE. Tietz Text Book of Clinical Chemistry and Molecular Diagnostics. 5th Edition. Amsterdam: Elsevier; 2012, NLMID.

Lubis M, Lubis AD, Nasution BB. The usefulness of C-reactive protein, procalcitonin, and PELOD-2 score as a predictive factor of mortality in sepsis. Indones Biomed J. 2020; 12(2): 85-188, CrossRef.


Copyright (c) 2023 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute